Guggenheim Capital LLC Dr Reddys Laboratories LTD Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Guggenheim Capital LLC holds 24,144 shares of RDY stock, worth $338,257. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,144

Previous 22,830 5.76%

Holding current value

$338,257

Previous $1.74 Million 10.29%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$75.41 - $84.21 $99,088 - $110,651	1,314 Added 5.76%	24,144 $1.92 Million
Q2 2024 Aug 14, 2024	BUY	$68.26 - $76.19 $45,597 - $50,894	668 Added 3.01%	22,830 $1.74 Million
Q1 2024 May 14, 2024	SELL	$67.36 - $77.59 $144,891 - $166,896	-2,151 Reduced 8.85%	22,162 $1.63 Million
Q4 2023 Feb 14, 2024	BUY	$64.27 - $69.9 $70,568 - $76,750	1,098 Added 4.73%	24,313 $1.69 Million
Q3 2023 Nov 14, 2023	BUY	$61.9 - $72.77 $145,774 - $171,373	2,355 Added 11.29%	23,215 $1.55 Million
Q2 2023 Aug 11, 2023	BUY	$53.34 - $63.11 $332,041 - $392,859	6,225 Added 42.54%	20,860 $1.32 Million
Q1 2023 May 10, 2023	BUY	$51.63 - $56.93 $509,226 - $561,500	9,863 Added 206.68%	14,635 $833,000
Q4 2022 Feb 14, 2023	SELL	$51.15 - $57.45 $8,184 - $9,192	-160 Reduced 3.24%	4,772 $246,000
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $18,862 - $21,666	-378 Reduced 7.12%	4,932 $258,000
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $78,697 - $92,194	1,586 Added 42.59%	5,310 $294,000
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $179,757 - $242,991	3,724 New	3,724 $207,000
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $200,492 - $250,790	-3,331 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$62.12 - $74.2 $206,921 - $247,160	3,331 New	3,331 $245,000
Q1 2021 May 13, 2021	SELL	$57.98 - $73.08 $180,897 - $228,009	-3,120 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$62.61 - $71.29 $5,008 - $5,703	80 Added 2.63%	3,120 $223,000
Q3 2020 Nov 13, 2020	BUY	$51.39 - $72.41 $156,225 - $220,126	3,040 New	3,040 $211,000
Q2 2018 Aug 14, 2018	SELL	$28.49 - $35.06 $252,506 - $310,736	-8,863 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$31.93 - $39.54 $46,905 - $58,084	-1,469 Reduced 14.22%	8,863 $290,000
Q4 2017 Feb 14, 2018	BUY	$34.15 - $37.62 $25,339 - $27,914	742 Added 7.74%	10,332 $388,000
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $288,754 - $361,734	9,590	9,590 $342,000

Others Institutions Holding RDY

# of Institutions

250

Shares Held

33.5M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.33B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Dr Reddys Laboratories LTD Transaction History